Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Abdayem

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society|July 22, 2021
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancerPamela Abdayem, David Planchard
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Ongoing progress in BRAF-mutated non-small cell lung cancerPamela Abdayem, David Planchard
Expert Opinion on Drug Safety|January 4, 2021
Safety of current immune checkpoint inhibitors in non-small cell lung cancerPamela Abdayem, David Planchard
Drugs|January 31, 2026
First Line and Treatment Sequencing in EGFR-Mutated Metastatic NSCLC: What is Right for Which Patient?Pamela Abdayem, Claudia Parisi, David Planchard
Lung Cancer (Amsterdam, Netherlands)|December 23, 2021
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancerAakash Desai, Pamela Abdayem, Alex A Adjei, et al.
World Journal of Gastroenterology|March 6, 2015
Anal cancer treatment: current status and future perspectivesMarwan Ghosn, Hampig Raphael Kourie, Pamela Abdayem, et al.
Reproductive Health|May 25, 2016
Feminine hygiene practices among female patients and nurses in LebanonElie Attieh, Samer Maalouf, Dina Roumieh, et al.
Reproductive Health|July 7, 2018
Impact of female gender and perspectives of pregnancy on admission in residency programsElie Attieh, Samer Maalouf, Cynthia Chalfoun, et al.
Cancer Treatment Reviews|October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectivesClaudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Journal of Cancer|April 12, 2014
Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the LiteraturePamela Abdayem, Marwan Ghosn, Vicente Valero, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Respiratory Review : an Official Journal of the European Respiratory Society|July 22, 2021
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancerPamela Abdayem, David Planchard
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Ongoing progress in BRAF-mutated non-small cell lung cancerPamela Abdayem, David Planchard
Expert Opinion on Drug Safety|January 4, 2021
Safety of current immune checkpoint inhibitors in non-small cell lung cancerPamela Abdayem, David Planchard
Drugs|January 31, 2026
First Line and Treatment Sequencing in EGFR-Mutated Metastatic NSCLC: What is Right for Which Patient?Pamela Abdayem, Claudia Parisi, David Planchard
Lung Cancer (Amsterdam, Netherlands)|December 23, 2021
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancerAakash Desai, Pamela Abdayem, Alex A Adjei, et al.
World Journal of Gastroenterology|March 6, 2015
Anal cancer treatment: current status and future perspectivesMarwan Ghosn, Hampig Raphael Kourie, Pamela Abdayem, et al.
Reproductive Health|May 25, 2016
Feminine hygiene practices among female patients and nurses in LebanonElie Attieh, Samer Maalouf, Dina Roumieh, et al.
Reproductive Health|July 7, 2018
Impact of female gender and perspectives of pregnancy on admission in residency programsElie Attieh, Samer Maalouf, Cynthia Chalfoun, et al.
Cancer Treatment Reviews|October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectivesClaudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Journal of Cancer|April 12, 2014
Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the LiteraturePamela Abdayem, Marwan Ghosn, Vicente Valero, et al.
Pageof 2